Mild Cognitive Impairment
Also known as: MCI · Pre-Dementia Cognitive Decline
Mild cognitive impairment is measurable cognitive change beyond normal aging without functional impairment. Vascular, metabolic, and hormonal drivers are partially modifiable.
What you need to know
Provider-reviewed assessment screens upstream drivers — ApoB, A1c, fasting insulin, hs-CRP, homocysteine, B12, vitamin D, thyroid panel, and hormone status. Neurology referral handles diagnostic confirmation; oMeds addresses modifiable physiology.
How this entity relates
Every entity in the oMeds knowledge graph cross-links to the conditions, biomarkers, medications, and educational surfaces it touches.
Diagnostic biomarkers
Bring this entity into your optimization pathway
Every condition, symptom, biomarker, and medication on oMeds is reviewed by a licensed provider and recalibrated against the standardized biomarker panel.

